Cacace Angela M
Chief Scientific Officer
Cacace Angela M has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jun 18, 2026.
On the most recent filing, Cacace Angela M is listed as Chief Scientific Officer at ARVINAS, INC. Inside the rolling window, Cacace Angela M reported no open-market purchases and 4 open-market sales totaling $214K in ARVN. The largest disclosed transaction in the window is a sale of 9,657 ARVN shares on May 11, 2026, worth $96K.
Companies traded
Other insiders at ARVN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$214K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cacace Angela M made?
Cacace Angela M has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Cacace Angela M trade?
Cacace Angela M has filed SEC Form 4 disclosures for 1 company, including ARVN.
When was Cacace Angela M's most recent SEC Form 4 filing?
Cacace Angela M's most recent SEC Form 4 filing on Tracefour is dated Jun 18, 2026.
What is Cacace Angela M's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cacace Angela M is listed as Chief Scientific Officer.
What is Cacace Angela M's total buy and sell value in the current window?
Inside the rolling retention window, Cacace Angela M bought $0 and sold $214K based on SEC Form 4 filings.
What was Cacace Angela M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 9,657 ARVN shares on 2026-05-11, worth $96K, per SEC Form 4 filings.